Skip to main content
logo
The Cooper Companies, Inc. (COO)
NASDAQ: COO · Real-Time Price · USD
69.30
+0.93 (1.36%)
Oct 13, 2025, 4:00 PM EDT - Market closed

Revenue

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 2012 - 2020
Toric Lens Revenue
--
Log In
Log In
Log In
Upgrade
Multifocal Lens Revenue
--
Log In
Log In
Log In
Upgrade
Toric and Multifocal Revenue
1.33B1.26B
Log In
Log In
Log In
Upgrade
Single-Use Sphere Lens Revenue
--
Log In
Log In
Log In
Upgrade
Non Single-Use Sphere Lens and Other Revenue
--
Log In
Log In
Log In
Upgrade
Sphere, Other Revenue
1.38B1.35B
Log In
Log In
Log In
Upgrade
Total CooperVision Revenue
2.71B2.61B
Log In
Log In
Log In
Upgrade
Office and Surgical Products Revenue
812.30M774.70M
Log In
Log In
Log In
Upgrade
Fertility Revenue
522.90M511.30M
Log In
Log In
Log In
Upgrade
Total CooperSurgical Revenue
1.34B1.29B
Log In
Log In
Log In
Upgrade
Revenue (Other)
-2.71B-2.61B
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.05B3.90B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 2012 - 2020
United States Revenue
1.80B1.97B
Log In
Log In
Log In
Upgrade
Europe Revenue
1.18B1.16B
Log In
Log In
Log In
Upgrade
Rest Of The World Revenue
723.80M773.60M
Log In
Log In
Log In
Upgrade
Revenue (Other)
341.90M-
Log In
Log In
Log In
Upgrade
Revenue (Total)
4.05B3.90B
Log In
Log In
Log In
Upgrade

EBIT

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 2012 - 2020
CooperVision Operating Income
761.40M676.20M
Log In
Log In
Log In
Upgrade
CooperSurgical Operating Income
71.10M118.30M
Log In
Log In
Log In
Upgrade
Corporate Operating Income
-91.60M-88.80M
Log In
Log In
Log In
Upgrade
Operating Income (Total)
740.90M705.70M
Log In
Log In
Log In
Upgrade

Key Performance Indicators

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212012 - 2020
Period Ending
Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 2012 - 2020
CooperVision - Constant Currency Revenue Growth
-8.00%
Log In
Log In
Log In
Upgrade
CooperSurgical - Constant Currency Revenue Growth
-11.00%
Log In
Log In
Log In
Upgrade
Total Company - Constant Currency Revenue Growth
-9.00%
Log In
Log In
Log In
Upgrade
CooperVision - Organic Revenue Growth
-9.00%
Log In
Log In
Log In
Upgrade
CooperSurgical - Organic Revenue Growth
-5.00%
Log In
Log In
Log In
Upgrade
Total Company - Organic Revenue Growth
-8.00%
Log In
Log In
Log In
Upgrade
Updated Aug 27, 2025. Data Source: Fiscal.ai.